1. Home
  2. Labeler Index
  3. Pharmacia & Upjohn Company Llc
  4. 0009-6582
  5. NDC Package Code: 0009-6582-01 Cleocin Phosphate (0009-6582) (standalone)

NDC Package 0009-6582-01 Cleocin Phosphate (0009-6582) (standalone)

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0009-6582-01
Package Description:
25 VIAL in 1 CARTON / 2 mL in 1 VIAL (0009-6582-02)
Product Code:
0009-6582
Proprietary Name:
Cleocin Phosphate (0009-6582) (standalone)
Usage Information:
CLEOCIN PHOSPHATE products are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.CLEOCIN PHOSPHATE products are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of antibiotic-associated pseudomembranous colitis, as described in the BOXED WARNING, before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin).Bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin.Indicated surgical procedures should be performed in conjunction with antibiotic therapy.CLEOCIN PHOSPHATE is indicated in the treatment of serious infections caused by susceptible strains of the designated organisms in the conditions listed below:Lower respiratory tract infections including pneumonia, empyema, and lung abscess caused by anaerobes, Streptococcus pneumoniae, other streptococci (except E. faecalis), and Staphylococcus aureus.Skin and skin structure infections caused by Streptococcus pyogenes, Staphylococcus aureus, and anaerobes.Gynecological infections including endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection caused by susceptible anaerobes.Intra-abdominal infections including peritonitis and intra-abdominal abscess caused by susceptible anaerobic organisms.Septicemia caused by Staphylococcus aureus, streptococci (except Enterococcus faecalis), and susceptible anaerobes.Bone and joint infections including acute hematogenous osteomyelitis caused by Staphylococcus aureus and as adjunctive therapy in the surgical treatment of chronic bone and joint infections due to susceptible organisms.To reduce the development of drug-resistant bacteria and maintain the effectiveness of CLEOCIN PHOSPHATE and other antibacterial drugs, CLEOCIN PHOSPHATE should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
11-Digit NDC Billing Format:
00009658201
NDC to RxNorm Crosswalk:
Labeler Name:
Pharmacia & Upjohn Company Llc
Sample Package:
No
FDA Application Number:
ANDA062803
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
10-16-1987
End Marketing Date:
09-30-2019
Listing Expiration Date:
09-30-2019
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0009-6582-01?

The NDC Packaged Code 0009-6582-01 is assigned to a package of 25 vial in 1 carton / 2 ml in 1 vial (0009-6582-02) of Cleocin Phosphate (0009-6582) (standalone), labeled by Pharmacia & Upjohn Company Llc. The product's dosage form is and is administered via form.

Is NDC 0009-6582 included in the NDC Directory?

No, Cleocin Phosphate (0009-6582) (standalone) with product code 0009-6582 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Pharmacia & Upjohn Company Llc on October 16, 1987 and its listing in the NDC Directory is set to expire on September 30, 2019 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 0009-6582-01?

The 11-digit format is 00009658201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20009-6582-015-4-200009-6582-01